IMCAS Asia 2026 will once again bring together leading experts in dermatology, plastic surgery, and aesthetic medicine to explore the innovations shaping the future of patient care across Asia and beyond.
From June 19 to 21, physicians, researchers, and industry leaders will meet to discuss new scientific perspectives, emerging technologies, and personalized approaches transforming clinical practice.
This year, Fagron Genomics will be at Stand MB3 with a strong scientific agenda focused on genetics, personalization, and the future of precision-driven healthcare.
As part of the congress, Dr. Gustavo Torres de Souza, Lead Geneticist at Fagron Genomics, will present several scientific sessions addressing women’s health, weight management, and hair loss through the lens of genetic stratification and personalized interventions.
Women’s Health
• MenoGen: Genetic Insights for Personalised Menopause Management
Weight Management
• Genetic Architecture of Obesity and Cardiometabolic Traits Predicts Response to GLP-1 Receptor Agonists
• Genetic Profiling for Personalised Weight Loss Interventions: SNP Associations, Interactions, and Pathway Insights
Hair Loss
• Genetic Stratification for Personalised Alopecia Therapy: SNP Associations, Interactions, and Pathway Insights
IMCAS Asia 2026 will also mark the pre-launch introduction of MenoGen, Fagron Genomics’ upcoming genetic solution designed to support more personalized approaches in menopause management.
Through these sessions and scientific exchanges, Fagron Genomics aims to contribute to the growing conversation around how genetics may help healthcare professionals better understand variability in treatment response, patient profiles, and individualized therapeutic strategies.
We look forward to welcoming healthcare professionals and partners at Stand MB3 during IMCAS Asia 2026.
